In particular, De Castro and coworkers demonstrated a critical role for T3 and T4 treatment in blunting the activation of the Toll-like receptor 4 (Tlr4)/NF-kB pro-inflammatory axis at two weeks following myocardial ischemia [68]. Here, TLR4 is linked to myocardial ischemia.